![]() |
市場調查報告書
商品編碼
1306982
全球非血管支架市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測Global Non-vascular Stents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
預計到2030年,全球非血管支架市場需求將從2022年的19.5億美元成長至32.9億美元,2023-2030年複合年成長率為6.8%。
非血管支架是用於治療胃腸道、呼吸道和泌尿道各種疾病的醫療器械。這些支架通常由金屬或塑膠製成,目的是撐開體內狹窄或堵塞的通道。
慢性疾病(癌症、慢性阻塞性肺病(COPD)和胃腸道疾病)在全球呈上升趨勢。非血管支架是用於治療這些疾病的重要醫療設備,預計將推動非血管支架市場的成長。新型先進支架設計的開發,如全覆蓋支架和可生物分解支架,已導致非血管支架的採用率上升。與傳統支架設計相比,這些支架具有更好的療效和安全性,導致對非血管支架的需求增加。非血管性支架通常採用內視鏡或支氣管鏡等微創手術置入,與傳統手術相比具有多項優勢。老齡人口罹患癌症和慢性阻塞性肺病等慢性疾病的風險較高,而這些疾病通常採用非血管支架進行治療。預計未來幾年老齡人口的增加將推動非血管支架的需求。非血管支架的保險給付政策因國家和醫療系統而異。非血管支架手術的保險給付可影響這些設備的採用並推動非血管支架市場的成長。
研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清楚地了解行業結構並評估全球競爭吸引力。此外,這些工具還對全球非血管支架市場的各個細分市場進行了全面評估。非血管支架行業的成長和趨勢為本研究提供了整體方法。
非血管支架市場報告的這一部分提供了國家和地區層面細分市場的詳細資料,幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域展望,重點介紹北美、歐洲、亞太、拉丁美洲以及中東和非洲地區非血管支架市場的當前和未來需求。此外,報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。
本研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。非血管支架市場的主要參與者包括Medtronic; C. R. Bard, Inc.; Boston Scientific Corporation; ELLA - CS, s.r.o.; CONMED Corporation; HOBBS MEDICAL, INC; Cook Medical; Taewoong Medical Co., Ltd.; Synchron Med Inc.; Glaukos Corporation。本部分包括競爭格局的整體視圖,其中包括各種戰略發展,如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
The global demand for Non-vascular Stents Market is presumed to reach the market size of nearly USD 3.29 BN by 2030 from USD 1.95 BN in 2022 with a CAGR of 6.8% under the study period 2023 - 2030.
Non-vascular stents are medical devices that are used to treat various conditions in the gastrointestinal (GI) tract, respiratory tract, and urinary tract. These stents are typically made of metal or plastic, and are designed to hold open a narrow or blocked passage in the body.
Chronic diseases (cancer, chronic obstructive pulmonary disease (COPD), and gastrointestinal disorders) are on the rise globally. Non-vascular stents are an important medical device used to treat these conditions, which is expected to drive the growth of the non-vascular stents market. The development of new and advanced stent designs, such as fully covered and biodegradable stents, has led to increased adoption of non-vascular stents. These stents offer improved efficacy and safety compared to traditional stent designs, leading to increased demand for non-vascular stents. Non-vascular stents are typically placed using minimally invasive procedures, such as endoscopy or bronchoscopy, which offer several advantages over traditional surgical procedures. The aging population is at higher risk for developing chronic diseases, such as cancer and COPD, which are commonly treated with non-vascular stents. The increase in aging population is expected to drive the demand for non-vascular stents in the coming years. The reimbursement policies for non-vascular stents vary by country and healthcare system. The availability of reimbursement for non-vascular stent procedures can influence the adoption of these devices and drive the growth of the non-vascular stents market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of non-vascular stents. The growth and trends of non-vascular stents industry provide a holistic approach to this study.
This section of the non-vascular stents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Non-vascular Stents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the non-vascular stents market include Medtronic; C. R. Bard, Inc.; Boston Scientific Corporation; ELLA - CS, s.r.o.; CONMED Corporation; HOBBS MEDICAL, INC; Cook Medical; Taewoong Medical Co., Ltd.; Synchron Med Inc.; Glaukos Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.